1 |
Weinstein-Oppenheimer, C. R., Henriquez-Roldan, C. F., Davis, J. M., Navolanic, P. M., Saleh, O. A., Steelman, L. S., Franklin, R. A., Robinson, P. J., McMahon, M. and McCubrey, J. A. (2001) Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin. Cancer Res. 7, 2898-2907.
|
2 |
Wu, C. P., Calcagno, A. M. and Ambudkar, S. V. (2008) Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr. Mol. Pharmacol. 1, 93-105.
DOI
|
3 |
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., Sedivy, J. M. and Kolch, W. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177.
DOI
|
4 |
Yusa, K. and Tsuruo, T. (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 49, 5002-5006.
|
5 |
Yusoff, P., Lao, D. H., Ong, S. H., Wong, E. S., Lim, J., Lo, T. L., Leong, H. F., Fong, C. W. and Guy, G. R. (2002) Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J. Biol. Chem. 277, 3195-3201.
DOI
|
6 |
Zhong, J., Troppmair, J. and Rapp, U. R. (2001) Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria. Oncogene 20, 4807-4816.
DOI
|
7 |
Kim, S. H., SH, L., NH, K., CD, K. and BS, C. (1996) Effect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter. Cancer Lett. 98, 199-205.
DOI
|
8 |
Lee, L. F., Haskill, J. S., Mukaida, N., Matsushima, K. and Ting, J. P. (1997) Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol. Cell. Biol. 17, 5097-5105.
|
9 |
Lee, M. (2006) Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2. Biochem. Biophys. Res. Commun. 350, 450-456.
DOI
|
10 |
Lee, M., Ahn, J. H. and Eum, K. H. (2009) The differences in biological properties between parental and v-Ha-ras transformed NIH3T3 cells. Cancer Res. Treat. 41, 93-99.
DOI
|
11 |
Lee, M., Koh, W. S. and Han, S. S. (2003) Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells. Cancer Lett. 193, 57-64.
DOI
|
12 |
Nobili, S., Landini, I., Giglioni, B. and Mini, E. (2006) Pharmacological strategies for overcoming multidrug resistance. Curr. Drug Targets 7, 861-879.
DOI
|
13 |
Marshall, M. S. (1995) Ras target proteins in eukaryotic cells. FASEB J. 9, 1311-1318.
|
14 |
McGrogan, B. T., Gilmartin, B., Carney, D. N. and McCann, A. (2008) Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 1785, 96-132.
|
15 |
Mercer, K. E. and Pritchard, C. A. (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653, 25-40.
|
16 |
Sasaki, A., Taketomi, T., Kato, R., Saeki, K., Nonami, A., Sasaki, M., Kuriyama, M., Saito, N., Shibuya, M. and Yoshimura, A. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5, 427-432.
DOI
|
17 |
Cornwell, M. M. and Smith, D. E. (1993) A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. J. Biol. Chem. 268, 15347-15350.
|
18 |
Davis, J. M., Navolanic, P. M., Weinstein-Oppenheimer, C. R., Steelman, L. S., Hu, W., Konopleva, M., Blagosklonny, M. V., McCubrey, J. A. (2003) Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. Clin. Cancer Res. 9, 1161-1170.
|
19 |
Dong, Y., Shao, S., Hu, J. and Yang, P. (2009) Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line. Oral Oncol. 45, 991-997.
DOI
|
20 |
Gottesman, M. M. (2002) Mechanisms of cancer drug resistanace. Annu. Rev. Med. 53, 615-627.
DOI
|
21 |
Gupta, K. P., Ward, N. E., Gravitt, K. R., Bergman, P. J. and O'Brian, C. A. (1996) Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. J. Biol. Chem. 271, 2102-2111.
DOI
|
22 |
Jazirehi, A. R., Vega, M. I., Chatterjee, D., Goodglick, L. and Bonavida, B. (2004) Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res. 64, 7117-7126.
DOI
|
23 |
Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y. and Krasnow, M. A. (1998) Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92, 253-263.
DOI
|
24 |
Haldar, S., Chintapalli, J. and Croce, C. M. (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56, 1253-1255.
|
25 |
Jaffrezou, J. P., Herbert, J. M., Levade, T., Gau, M. N., Chatelain, P. and Laurent, G. (1991) Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein. J. Biol. Chem. 266, 19858-19864.
|
26 |
Abrams, S. L., Steelman, L. S., Shelton, J. G., Wong, E. W., Chappell, W. H., Basecke, J., Stivala, F., Donia, M., Nicoletti, F., Libra, M., Martelli, A. M. and McCubrey, J. A. (2010) The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. Cell Cycle 9, 1781-1791.
DOI
|
27 |
Ahn, J. H., Eum, K. H. and Lee, M. (2009) The enhancement of Raf-1 kinase activity by knockdown of Spry2 is associated with high sensitivity to paclitaxel in v-Ha-ras-transformed NIH 3T3 fibroblasts. Mol. Cell. Biochem. 332, 189-197.
DOI
|
28 |
Callaghan, R. and Higgins, C. F. (1995) Interaction of tamoxifen with the multidrug resistance P-glycoprotein. Br. J. Cancer 71, 294-299.
DOI
|
29 |
Ahn, J. H., Eum, K. H. and Lee, M. (2010) Spry2 does not directly modulate Raf-1 kinase activity in v-Ha-ras-transformed NIH 3T3 fibroblasts. BMB Rep. 43, 205-211.
과학기술학회마을
DOI
|
30 |
Blobe, G. C., Sachs, C. W., Khan, W. A., Fabbro, D., Stabel, S., Wetsel, W. C., Obeid, L. M., Fine, R. L. and Hannun, Y. A. (1993) Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. J. Biol. Chem. 268, 658-664.
|
31 |
Chatterjee, D., Bai, Y., Wang, Z., Beach, S., Mott, S., Roy, R., Braastad, C., Sun, Y., Mukhopadhyay, A., Aggarwal, B. B., Darnowski, J., Pantazis, P., Wyche, J., Fu, Z., Kitagwa, Y., Keller, E. T., Sedivy, J. M. and Yeung, K. C. (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J. Biol. Chem. 279, 17515-17523.
DOI
|